Table 2 Effect of Olmesartan Medoxomil on cytokine levels in bronchoalveolar lavage fluid
From: Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice
Day 7 |  | TNF-α (pg/ml) | MCP-1 (pg/ml) | TGF-β1 (pg/ml) |
|  | BLM (n = 8) | 20.7 ± 1.7 | 766.3 ± 100.6 | 331.3 ± 17.7 |
|  | BLM + OL (n = 8) | 15.6 ± 1.6 * | 701.3 ± 97.6 | 318.3 ± 29.9 |
|  | OL (n = 8) | 5.1 ± 0.0 | 2.0 ± 0.0 | 19.9 ± 3.4 |
Day 14 |  | MIP-2 (pg/ml) | TGF-β1 (pg/ml) |  |
|  | BLM (n = 8) | 7.1 ± 2.4 | 287.9 ± 35.2 |  |
|  | BLM + OL (n = 8) | 1.5 ± 0 | 173.4 ± 49.9 * |  |
|  | OL (n = 8) | 1.5 ± 0 | 21.2 ± 7.3 |  |